Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
MODIFIED STEM CELL COMPOSITIONS AND METHODS FOR USE
Document Type and Number:
WIPO Patent Application WO/2024/036214
Kind Code:
A3
Abstract:
Disclosed herein is a modified cell comprising one, two, or more exogenous or introduced nucleic acid sequences, each encoding a CD47, a modified CD117, and/or a CXCR4 polypeptide, including functional fragments or variants thereof. In some embodiments, the CD47, modified CD117, and/or CXCR4 polypeptides are transiently expressed in the cell. In some embodiments, the nucleic acid sequence comprises, optionally from 5' to 3': a 5' UTR, a 5' terminal cap sequence, a sequence encoding the CXCR4, CD47, and/or a modified CD117 protein, a stop codon, and a 3' UTR.

Inventors:
PANG WENDY (US)
TIWARI RAJIV (US)
KWON HYE-SOOK (US)
SHIZURU JUDITH (US)
SIKORSKI ROBERT (US)
D’ESPAUX LEOPOLD (US)
LEE SONG EUN (US)
Application Number:
PCT/US2023/071937
Publication Date:
April 18, 2024
Filing Date:
August 09, 2023
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
JASPER THERAPEUTICS INC (US)
International Classes:
A61K35/12; A61K35/545; C12N5/0789
Attorney, Agent or Firm:
LAHERTY, Carol et al. (US)
Download PDF: